Jerome D G Comes, Kristel Doets, Thijmen Zegers, Merel Kessler, Irene Slits, Natalia A Ballesteros, Noortje M P van de Weem, Henk Pouwels, Monique M van Oers, Marielle C W van Hulten, Martijn Langereis, Gorben P Pijlman
Each year, millions of poultry succumb to highly pathogenic avian influenza A virus (AIV) and infectious bursal disease virus (IBDV) infections. Conventional vaccines based on inactivated or live-attenuated viruses are useful tools for disease prevention and control, yet, they often fall short in terms of safety, efficacy, and development times. Therefore, versatile vaccine platforms are crucial to protect poultry from emerging viral pathogens. Self-amplifying (replicon) RNA vaccines offer a well-defined and scalable option for the protection of both animals and humans...
March 22, 2024: Vaccine